The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain
In the majority of patients with breast cancer in the advanced stages, skeletal metastases are common, which may cause excruciating pain. Currently available drug treatments for relief of breast cancer-induced bone pain (BCIBP) include non-steroidal anti-inflammatory drugs and strong opioid analgesi...
Main Authors: | Priyank A. Shenoy, Andy Kuo, Nemat Khan, Louise Gorham, Janet R. Nicholson, Laura Corradini, Irina Vetter, Maree T. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00495/full |
Similar Items
-
J-2156, a somatostatin receptor type 4 agonist, alleviates mechanical hyperalgesia in a rat model of chronic low back pain
by: Thomas S.W. Park, et al.
Published: (2019-09-01) -
Methods Used to Evaluate Pain Behaviors in Rodents
by: Jennifer R. Deuis, et al.
Published: (2017-09-01) -
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats
by: Priyank Ashok Shenoy, et al.
Published: (2016-08-01) -
Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods
by: Priyank Shenoy, et al.
Published: (2017-07-01) -
The role of NMDA receptors in the effects of corticosterone on CCI model neuropathic pain in rats
by: S. Faryadian, et al.
Published: (2008-05-01)